Davide Rossi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Davide Rossi has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Gian Domenico Pinna
Laboratory for the Study of Ventilatory Instability, Department of Biomedical Engineering, Montescano Institute - IRCCS, Istituti Clinici Scientifici Maugeri, Montescano, Italy
2 shared publications C. Opasich
Salvatore Maugeri Foundation, Institute of Care and Research, Montescano Medical Center Montescano, Pavia, Italy
1 shared publication- Edoardo De Meis
Department of Surgery, Sapienza University of Rome, Viale Regina Elena, 324, 00161 Rome, Italy
1 shared publication Egidio Traversi
From the Maugeri Foundation, Institute of Care and Scientific Research, Medical Center, Montescano (Pavia, Italy
1 shared publication- Egidio Traversi
Department of Cardiology, Salvatore Maugeri Foundation, IRCCS , Scientific Institute of Montescano , Montescano, Pavia 27040 , Italy
1 shared publication - Egidio Traversi
Istituti Clinici Scientifici Maugeri IRCCS, Scientific Institute of Pavia
1 shared publication
Latest Publications
- 1 December 2021
- Published by Galenos Yayinevi in Turkish Journal of Colorectal Disease
- Vol. 31 (4) , 300-308
Comparison Between Primary Resection Anastomosis and Hartmann Procedure for the Treatment of Hinchey III and IV Acute Diverticulitis in the Emergency Setting
- 1 December 2021
- Published by Galenos Yayinevi in Turkish Journal of Colorectal Disease
- Vol. 31 (4) , 300-308
Comparison Between Primary Resection Anastomosis and Hartmann Procedure for the Treatment of Hinchey III and IV Acute Diverticulitis in the Emergency Setting
- Open Access
- 28 October 2010
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 12 (2) , 112-119
Prognostic significance of tissue-Doppler imaging in chronic heart failure patients on transplant waiting list: a comparative study with right heart catheterization
Several echo-Doppler parameters, particularly the E/e′ ratio, have been explored in the attempt to improve prognostic stratification in chronic heart failure (CHF) patients. In most studies, however, left ventricular filling pressure was not measured and patients with severe impairment of left ventricular function were not considered. The aim of this study was to assess the prognostic value of E/e′ when compared with both traditional echo-Doppler parameters and pulmonary wedge pressure (PWP) in patients with advanced CHF. Right heart catheterization and a two-dimensional echo-Doppler examination were performed at baseline in 49 patients (male: 88%, age: 53 ± 9 years, New York Heart Association class: 2.7 ± 0.7, left ventricular ejection fraction: 29 ± 7%). Traditional pulsed-wave and tissue Doppler velocity parameters (DT, E, SFPVF, E′, and E/e′) were measured. Endpoint of survival analysis was cardiac death or urgent transplantation. During a median follow-up of 47 months (range: 1–58), 18 patients had experienced a major event (cardiac death or urgent transplantation). Both DT and E/e′ were significantly and independently associated with the outcome (the Cox analysis), but the strength of the association was stronger for the latter (P= 0.008 vs. P= 0.03). Moreover, DT became non-significant when adjusted for PWP, whereas E/e′ preserved its prognostic value (P= 0.04). The prognostic value of E′ and PWP was borderline non-significant or clearly non-significant in both univariate and multivariable analyses. Among the echo-Doppler parameters, E/e′ shows the highest predictive value in patients with advanced CHF and provides prognostic information independent of PWP. These results support the use of the feasible and easy obtainable E/e′ ratio as a prognostic indicator in these patients.
- 28 October 2010
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 12 (2) , 112-119
Open AccessPrognostic significance of tissue-Doppler imaging in chronic heart failure patients on transplant waiting list: a comparative study with right heart catheterization
Several echo-Doppler parameters, particularly the E/e′ ratio, have been explored in the attempt to improve prognostic stratification in chronic heart failure (CHF) patients. In most studies, however, left ventricular filling pressure was not measured and patients with severe impairment of left ventricular function were not considered. The aim of this study was to assess the prognostic value of E/e′ when compared with both traditional echo-Doppler parameters and pulmonary wedge pressure (PWP) in patients with advanced CHF. Right heart catheterization and a two-dimensional echo-Doppler examination were performed at baseline in 49 patients (male: 88%, age: 53 ± 9 years, New York Heart Association class: 2.7 ± 0.7, left ventricular ejection fraction: 29 ± 7%). Traditional pulsed-wave and tissue Doppler velocity parameters (DT, E, SFPVF, E′, and E/e′) were measured. Endpoint of survival analysis was cardiac death or urgent transplantation. During a median follow-up of 47 months (range: 1–58), 18 patients had experienced a major event (cardiac death or urgent transplantation). Both DT and E/e′ were significantly and independently associated with the outcome (the Cox analysis), but the strength of the association was stronger for the latter (P= 0.008 vs. P= 0.03). Moreover, DT became non-significant when adjusted for PWP, whereas E/e′ preserved its prognostic value (P= 0.04). The prognostic value of E′ and PWP was borderline non-significant or clearly non-significant in both univariate and multivariable analyses. Among the echo-Doppler parameters, E/e′ shows the highest predictive value in patients with advanced CHF and provides prognostic information independent of PWP. These results support the use of the feasible and easy obtainable E/e′ ratio as a prognostic indicator in these patients.
- 1 December 1996
- Published by Elsevier in The American Journal of Cardiology
- Vol. 78 (11) , 1317-1321
Assessment of right ventricular function in patients with congestive heart failure by echocardiographic automated boundary detection
- 1 December 1996
- Published by Elsevier in The American Journal of Cardiology
- Vol. 78 (11) , 1317-1321
Assessment of right ventricular function in patients with congestive heart failure by echocardiographic automated boundary detection
- Open Access
- 1 September 1996
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 17 (9) , 1381-1389
Systemic thromboembolism in chronic heart failure: A prospective study in 406 patients
In patients with heart failure the risk of systemic thromboembolism and the benefit of anticoagulation are uncertain. To assess the incidence of systemic thromboembolism and the factors associated with an increased risk, 406 consecutive patients with chronic heart failure were prospectively investigated. Their left ventricular ejection fraction was 23±8%, pulmonary wedge pressure 19±10 mmHg and cardiac index 2.3±1.41. min−1 . m−2 of body surface area. Two hundred patients were in NYHA functional class III-IV. Two hundred and thirty-two patients were receiving oral anticoagulants. Over a follow-up period of 16±11 months, thromboembolism occurred in 11 patients (2.7%), seven of whom were on anticoagulants. Among clinical, echocardiographic and haemodynamic variables, atrial fibrillation, more severe haemodynamic impairment and low exercise capacity were associated with increased thromboembolic risk. No echocardiographic findings, including the presence of intracavitary thrombi, either at baseline or during follow-up, were related to subsequent thromboembolic events. The rate of embolism did not differ in patients receiving anticoagulants (4%) compared with those who did not receive anticoagulants (1%). No major bleeding occurred during follow-up. Thus, in patients with chronic heart failure and sinus rhythm the incidence of systemic thromboembolism is low regardless of anti coagulant treatment. Atrial fibrillation, particularly when associated with low cardiac index, identifies a subgroup of patients at high risk of events. In this subgroup, a moderate-intensity anticoagulant regimen provides unsatisfactory protection against thromboembolism.
- 1 September 1996
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 17 (9) , 1381-1389
Open AccessSystemic thromboembolism in chronic heart failure: A prospective study in 406 patients
In patients with heart failure the risk of systemic thromboembolism and the benefit of anticoagulation are uncertain. To assess the incidence of systemic thromboembolism and the factors associated with an increased risk, 406 consecutive patients with chronic heart failure were prospectively investigated. Their left ventricular ejection fraction was 23±8%, pulmonary wedge pressure 19±10 mmHg and cardiac index 2.3±1.41. min−1 . m−2 of body surface area. Two hundred patients were in NYHA functional class III-IV. Two hundred and thirty-two patients were receiving oral anticoagulants. Over a follow-up period of 16±11 months, thromboembolism occurred in 11 patients (2.7%), seven of whom were on anticoagulants. Among clinical, echocardiographic and haemodynamic variables, atrial fibrillation, more severe haemodynamic impairment and low exercise capacity were associated with increased thromboembolic risk. No echocardiographic findings, including the presence of intracavitary thrombi, either at baseline or during follow-up, were related to subsequent thromboembolic events. The rate of embolism did not differ in patients receiving anticoagulants (4%) compared with those who did not receive anticoagulants (1%). No major bleeding occurred during follow-up. Thus, in patients with chronic heart failure and sinus rhythm the incidence of systemic thromboembolism is low regardless of anti coagulant treatment. Atrial fibrillation, particularly when associated with low cardiac index, identifies a subgroup of patients at high risk of events. In this subgroup, a moderate-intensity anticoagulant regimen provides unsatisfactory protection against thromboembolism.